Others have supported the concept that chemerin may be a promising immunotherapeutic approach as elevated chemerin expression within TME of breast cancer tissue suppressed growth by enrollment of immune cells, notably NK and T cells [159]. This evidence concerns the gene RARRES2 and breast carcinoma.